This week PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, DigiHealth, MedTech, Biosimilars, Animal Health & Biotech. Check out our full report below:
Novo Nordisk Reports Headline Results from P-IIIb (STEP UP) Study of Semaglutide 7.2mg in Obese Adults without Diabetes
Read More: Novo Nordisk
Yoltech Initiates a Dose-Escalation Study for YOLT-204 to Treat β -Thalassemia
Read More: Yoltech
Antennova to Highlight P-I/II (CLINCH) Trial Data of ATN-022 to Treat Advanced/Metastatic Gastric Cancer at ASCO GI 2025
Read More: Antennova
Coherus to Highlight Final P-II Study Data of Casdozokitug Regimen to Treat Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Read More: Coherus
Tris Pharma Reports the P-III (ALLEVIATE-1) Study Results of Cebranopadol to Treat Moderate-to-Severe Acute Pain
Read More: Tris Pharma
Agenus Highlights Data from Five Studies of Botensilimab/Balstilimab (BOT/BAL) Regimen as Multiple lines of Therapy in Colorectal Cancer at ASCO GI 2025
Read More: Agenus
Rakuten Medical Commences Global P-III (ECLIPSE) Study of ASP-1929 Plus Keytruda as a 1L Treatment of Recurrent Head and Neck Cancer
Read More: Rakuten Medical
Lisata Therapeutics and WARPNINE Reports Initial Results from P-Ib/IIa (iLSTA) trial of Certepetide Regimen in Pancreatic Ductal Adenocarcinoma (PDAC)
Read More: Lisata Therapeutics and WARPNINE
Amgen Receives the US FDA Approval for Lumakras + Vectibix to Treat Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer (mCRC)
Read More: Amgen
Daiichi Sankyo and AstraZeneca Receives the US FDA Approval for Datroway (Datopotamab Deruxtecan-dlnk) to Treat HR+/HER2- Metastatic Breast Cancer
Read More: Daiichi Sankyo and AstraZeneca
AstraZeneca’s Calquence (Acalabrutinib) Plus Chemoimmunotherapy Secures the US FDA’s Approval for Mantle Cell Lymphoma (MCL)
Read More: AstraZeneca
GSK’s Jemperli Plus Chemotherapy Receives the EC’s Approval as a 1L Treatment of Primary Advanced or Recurrent Endometrial Cancer
Read More: GSK
Takeda Receives Health Canada’s Approval for Fruzaqla (fruquintinib) to Treat Metastatic Colorectal Cancer (mCRC)
Read More: Takeda
The US FDA Approves sNDA for J&J’s Spravato (esketamine) to Treat Major Depressive Disorder (MDD)
Read More: J&J
The EC Approves Sanofi’s Sarclisa + standard-of-care VRd to Treat Newly Diagnosed Multiple Myeloma (NDMM)
Read More: Sanofi
Solid Biosciences’ SGT-212 Secures the US FDA’s Fast Track Designation for Treating Friedreich’s Ataxia
Read More: Solid Biosciences
Zai Lab’s ZL-1310 Secures the US FDA’s Orphan Drug Designation to Treat Small Cell Lung Cancer (SCLC)
Read More: Zai Lab
Fermion Technology and Simcere Pharma Join Hands to Develop FZ002-037 for Pain Management
Read More: Fermion Technology and Simcere Pharma
InnoCare and KeyMed Together Partner with Prolium Bioscience to Develop ICP-B02
Read More: InnoCare and KeyMed
Junshi Biosciences & LEO Pharma Collaborate to Commercialize Toripalimab in Europe
Read More: Junshi Biosciences and LEO Pharma
ArriVent Biopharma Collaborates with Lepu BioPharma to Develop and Commercialize MRG007 for the Treatment of Gastrointestinal Cancers
Read More: ArriVent Biopharma and Lepu BioPharma
Abbvie Partners with Neomorph to Develop Novel Molecular Glue Degraders for Oncology and Immunology
Read More: Abbvie and Neomorph
IMMvention Therapeutix Partners with Novo Nordisk to Develop Oral BACH1 inhibitors for Chronic Conditions
Read More: IMMvention Therapeutix and Novo Nordisk
Holon Health Reports Development of Holon Vibe App for the People with Substance Use Disorders (SUD)
Read More: Holon Health
The US FDA Approves Innovate’s MediBeacon Transdermal GFR System to Evaluate Renal Function
Read More: Innovate
Roche Receives 510(k) Clearance & CLIA Waiver for Cobas Liat Multiplex Assay Panels to Diagnose Sexually Transmitted Infections
Read More: Roche
Medidata (Dassault Systèmes brand) and Tigermed Expand their Strategic Collaboration to Expedite Clinical Trials Globally
Read More: Medidata and Tigermed
Formycon Reports the EC’s Approval of FYB203 (Biosimilar, Eylea) Under the Brand Names Ahzantive and Baiama
Read More: Formycon
Virbac Launches Zenifel Pheromone Product to Address Stress-Related Behaviors in Cats
Read More: Virbac
Tiziana Life Sciences Identifies New Immune Biomarkers in Multiple Sclerosis Patients Treated with Foralumab
Read More: Tiziana Life Sciences
Related Post: PharmaShots Weekly Snapshots (January 13, 2025 – January 17, 2025)
